期刊论文详细信息
BMC Pediatrics
Neurofeedback in children with attention-deficit/hyperactivity disorder (ADHD) – a controlled multicenter study of a non-pharmacological treatment approach
Ute Strehl1  Sonja Wörz1  Daniel Wachtlin2  Benjamin Pniewski3  Martin Holtmann3 
[1] Institute of Medical Psychology and Behavioral Neurobiology, Eberhard-Karls-University Tübingen, Silcherstr. 5, 72076 Tübingen, Germany;Interdisciplinary Centre for Clinical Trials (German abb.: IZKS), University Medical Centre Mainz, Langenbeckstr. 255131 Mainz, Germany;Hospital for Child and Adolescent Psychiatry, LWL University Hospital Hamm of the Ruhr-University Bochum, Heithofer Allee 64, 59071 Hamm, Germany
关键词: EMG biofeedback;    Electromyogram;    Attention-deficit/hyperactivity disorder;    ADHD;    Slow cortical potentials;    SCP;    Neurofeedback;   
Others  :  1137317
DOI  :  10.1186/1471-2431-14-202
 received in 2014-06-26, accepted in 2014-08-07,  发布年份 2014
PDF
【 摘 要 】

Background

Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood and has often a chronic course persisting into adulthood. However, up to 30% of children treated with stimulants either fail to show an improvement or suffer adverse side effects, including decreased appetite, insomnia and irritability and there is no evidence of long term efficacy of stimulants for ADHD. A series of studies has shown that neurofeedback is an effective additional or alternative treatment for children with ADHD, leading to e.g. significant and stable improvement in behavior, attention and IQ. Significant treatment effects of neurofeedback have also been verified in meta-analyses. Most of the trials, however, have been criticized for methodological difficulties, particularly lacking appropriate control conditions and number of patients included. This randomized study examines the efficacy of slow cortical potentials (SCP) -neurofeedback, controlling unspecific effects of the setting by comparing two active treatment modalities.

Methods/Design

A total of 144 patients with ADHD, older than six and younger than ten years, in some cases with additional pharmacological treatment, are included in this trial. In five trial centres patients are treated either with SCP-feedback or electromyographic (EMG) -feedback in 25 sessions within 3 months. A comprehensive test battery is conducted before and after treatment and at follow-up 6 month later, to assess core symptoms of ADHD, general psychopathology, attentional performance, comorbid symptoms, intelligence, quality of life and cortical arousal.

Discussion

The efficacy of SCP-feedback training for children with ADHD is evaluated in this randomized controlled study. In addition to behavior ratings and psychometric tests neurophysiological parameters serve as dependent variables. Further, the choice of EMG-biofeedback as an active control condition is debated.

Trials registration

Current Controlled Trials ISRCTN76187185. Registered 5 February 2009.

【 授权许可】

   
2014 Holtmann et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150316031123609.pdf 300KB PDF download
Figure 1. 42KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lepine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R: Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007, 190:402-409.
  • [2]Polanczyk G, De Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007, 164:942-948.
  • [3]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, DSM-V. 5th edition. Washington, DC: American Psychiatric Association (APA); 2013.
  • [4]Faraone SV, Biederman J, Mick E: The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006, 36:159-165.
  • [5]DuPaul GJ, Barkley RA, Connor DF: Stimulants. In Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. Edited by Barkley RA. New York, NY: Guilford Press; 1998:510-551.
  • [6]Swanson J, Kraemer H, Hinshaw S, Arnold L, Conners C, Abikoff H, Clevenger W, Davies M, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Owens EB, Pelham WE, Schiller E, Severe JB, Simpson S, Vitiello B, Wells K, Wigal T, Wu M: Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001, 40:168-179.
  • [7]MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999, 56:1073-86.
  • [8]Kratochvil CJ, Wilens TE, Greenhill LL, Gao H, Baker KD, Feldman PD, Gelowitz DL: Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006, 45:919-927.
  • [9]Banaschewski T, Brandeis D: Annotation: what electrical brain activity tells us about brain function that other techniques cannot tell us - a child psychiatric perspective. J Child Psychol Psychiatry 2007, 48:415-435.
  • [10]Clarke AR, Barry RJ, McCarthy R, Selikowitz M: EEG-defined subtypes of children with attention-deficit/hyperactivity disorder. Clin Neurophysiol 2001, 112:2098-2105.
  • [11]Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Brown CR: EEG evidence for a new conceptualisation of attention deficit hyperactivity disorder. Clin Neurophysiol 2002, 113:1036-1044.
  • [12]Becker K, Holtmann M: The role of EEG in Attention-Deficit/Hyperactivity Disorder. Expert Rev Neurother 2006, 6:731-739.
  • [13]Holtmann M, Stadler C: Electroencephalographic-biofeedback for the treatment of attention-deficit/hyperactivity disorder in childhood and adolescence. Expert Rev Neurother 2006, 6:533-540.
  • [14]Leins U, Goth G, Hinterberger T, Klinger C, Rumpf N, Strehl U: Neurofeedback for children with ADHD: a comparison of SCP and Theta/Beta protocols. Appl Psychophysiol Biofeedback 2007, 32:73-88.
  • [15]Strehl U, Leins U, Goth G, Klinger C, Hinterberger T, Birbaumer N: Self-regulation of slow cortical potentials: a new treatment for children with attention-deficit/hyperactivity disorder. Pediatrics 2006, 118:e1530-40.
  • [16]Gani C, Birbaumer N, Strehl U: Long term effects after feedback of slow cortical potentials and of theta-beta-amplitudes in children with attention deficit/hyperactivity disorder (ADHD). Int J Bioelectromagn 2008, 10:209-232.
  • [17]Holtmann M, Stadler S, Zepf F, Hager V, Panzner N, Poustka F: Specific effects of neurofeedback on impulsivity in ADHD: evidence from a prospective randomized pilot study [abstract]. J Neural Transm 2007, 114:LIX.
  • [18]Heinrich H, Gevensleben H, Freisleder FJ, Moll GH, Rothenberger A: Training of slow cortical potentials in attention-deficit/hyperactivity disorder: evidence for positive behavioral and neurophysiological effects. Biol Psychiatry 2004, 55:772-775.
  • [19]Lévesque J, Beauregard M, Mensour B: Effects of neurofeedback training on the neural substrates of selective attention in children with ADHD: a functional magnetic resonance imaging study. Neurosci Lett 2006, 349:216-221.
  • [20]Ghaziri J, Tucholka A, Larue V, Blanchette-Sylvestre M, Reyburn G, Gilbert G, Lévesque J, Beauregard M: Neurofeedback Training Induces Changes in White and Gray Matter. Clin EEG Neurosci 2013, 44:265-272.
  • [21]Arns M, De Ridder S, Strehl U, Breteler M, Coenen : A Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis. Clin. EEG Neurosci 2009, 40:180-189.
  • [22]Sonuga-Barke EJS, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, Van der Oord S, Döpfner M, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong ICK, Sergeant J, European ADHD, Guidelines Group: Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 2013, 170:275-289.
  • [23]Heinrich H, Gevensleben H, Strehl U: Annotation: neurofeedback - train your brain to train behaviour. J Child Psychol Psychiatry 2007, 48:3-16.
  • [24]Delmo C, Weifenbach O, Gabriel M, Stadler C, Poustka F: KIDDIE-SADS present und lifetime version (K-SADS-PL). Deutsche Forschungsversion. Frankfurt/M: Universitätsklinik für Kinder- und Jugendpsychiatrie; 1998.
  • [25]Bakhshayesh AR, Hansch S, Wyschkon A, Rezai MJ, Esser G: Neurofeedback in ADHD: a single-blind randomized controlled trial. Eur Child Adolesc Psychiatry 2011, 20:481-491.
  • [26]Drechsler R, Straub M, Doehnert M, Heinrich H, Steinhausen HC, Brandeis D: Controlled evaluation of a neurofeedback training of slow cortical potentials in children with attention deficit/hyperactivity disorder (ADHD). Behav Brain Funct 2007, 3:35.
  • [27]Leins U, Hinterberger T, Kaller S, Schober F, Weber C, Strehl U: Neurofeedback for children with ADHD: a comparison of SCP – and q/b-protocols. Prax Kinderpsychol Kinderpsychiatr 2006, 55:384-407.
  • [28]Gevensleben H, Holl B, Albrecht B, Vogel C, Schlamp D, Kratz O, Studer P, Rothenberger A, Moll GH, Heinrich H: Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. J Child Psychol Psychiatry 2009, 50:780-789.
  • [29]Gevensleben H, Herrmann B, Albrecht B, Vogel C, Schlamp D, Kratz O, Studer P, Rothenberger A, Moll GH, Heinrich H: Neurofeedback in children with ADHD: intermediate clinical and neurophysiological results of a multisite study [abstract]. J Neural Transm 2007, 114:LIX.
  • [30]Arns M, Heinrich H, Strehl U: Evaluation of neurofeedback in ADHD: the long and winding road. Biol Psychol 2014, 95:108-115.
  • [31]Görtz-Dorten A, Döpfner M: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen von Kindern und Jugendlichen im Elternurteil. Z Kinder Jugendpsychiatr Psychoth 2009, 37:183-194.
  • [32]Brühl B, Döpfner M, Lehmkuhl G: Der Fremdbeurteilungsbogen für hyperkinetische Störungen (FBB-HKS)–Prävalenz hyperkinetischer Störungen im Elternurteil und psychometrische Kriterien. Kindheit und Entwicklung 2000, 9:115-125.
  • [33]Döpfner M, Lehmkuhl G, Steinhausen HC: Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen (FBB-ADHS). KIDS Kinder-Diagnostik-System 2006, 1:61-69.
  • [34]Guy W: ECDEU Assessment Manual for Psychopharmacology – Revised (DHEW Publ No ADM 76–338). Rockville, MD: US Department of Health, Education, and Welfare; Public Health Service; Alcohol, Drug Abuse, and Mental Health Administration; NIMH Psychopharmacology Research Branch; Division of Extramural Research Programs; 1976:218-222.
  • [35]Guy W: Clinical Global Impressions (CGI) Scale. In Psychiatric Measures. Edited by Rush J. Washington, DC: APA; 2000.
  • [36]Zimmermann P, Fimm B: TAP Testbatterie zur Aufmerksamkeitsprüfung (Version 2.1). Herzogenrath: Psytest; 2007.
  • [37]Rosvold HE, Mirsky AF, Sarason I, Bransome ED Jr, Beck LH: A continuous performance test of brain damage. J Consult Psychol 1956, 20:343-350.
  • [38]Van Leeuwen TH, Steinhausen HC, Overtoom CCE, Pascual-Marqui RD, Van’t Klooster B, Rothenberger A, Sergeant JA, Brandeis D: The continuous performance test revisited with neuroelectric mapping: impaired orienting in children with attention deficits. Behav Brain Res 1998, 94:97-110.
  • [39]Albrecht B, Brandeis D, Uebel H, Heinrich H, Mueller UC, Hasselhorn M, Steinhausen HC, Rothenberger A, Banaschewski T: Action monitoring in boys with attention-deficit/hyperactivity disorder, their nonaffected siblings, and normal control subjects: Evidence for an endophenotype. Biol Psychiatry 2008, 64:615-625.
  • [40]Döpfner M, Schmeck K, Berner W, Lehmkuhl G, Poustka F: Reliability and factorial validity of the child behavior checklist–an analysis of a clinical and field sample. Z Kinder Jugendpsychiatr 1994, 22:189-205.
  • [41]Althoff RR: Dysregulated children reconsidered. J Am Acad Child Adolesc Psychiatry 2010, 49:302-305.
  • [42]Schmeck K, Poustka F, Döpfner M, Pluck J, Berner W, Lehmkuhl G, Fegert JM, Lenz K, Huss M, Lehmkuhl U: Discriminant validity of the child behaviour checklist CBCL-4/18 in German samples. Eur Child Adolesc Psychiatry 2001, 10:240-247.
  • [43]Döpfner M, Lehmkuhl G: Diagnostic Checklist for Depressive Disorders (DISYPS-KJ—Diagnostik-System für psychische Störungen im Kindes- und Jugendalter). Bern: Hans Huber; 2000.
  • [44]Goodman R: The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry 1997, 38:581-586.
  • [45]Holtmann M, Becker A, Banaschewski T, Rothenberger A, Roessner V: Psychometric validity of the strengths and difficulties questionnaire-dysregulation profile. Psychopathology 2011, 44:53-59.
  • [46]Goodman R: Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry 2001, 40:1337-1345.
  • [47]Bulheller S, Häcker H, et al.: Standard Progressive Matrices. Deutsche Bearbeitung und Normierung. In Manual for Raven’s Progressive Matrices und Vocabulary Scales. Part 4: Advanced Progressive Matrices. Edited by Raven J. Frankfurt/M: Swets Test Services; 1998.
  • [48]Ravens-Sieberer U, Bullinger M: News from the KINDL-questionnaire: A new version for adolescents. Qual Life Res 1998, 7:653-653.
  • [49]Bullinger M, Brütt DPAL, Erhart M, Ravens-Sieberer U: Psychometric properties of the KINDL-R questionnaire: results of the BELLA study. Eur Child Adolesc Psychiatry 2008, 17:125-132.
  • [50]Institut für Medizinische Psychologie und Verhaltensneurobiologie: Fragebogen zur Erfassung der Therapiezufriedenheit (unpublished questionnaire). Tübingen: Eberhard-Karls-University; 2004.
  • [51]Birbaumer N, Elbert T, Rockstroh B, Daum I, Wolf P, Canavan A: Clinical-psychological treatment of epileptic seizures: a controlled study. In Perspectives and promises in clinical psychology. 1st edition. Edited by Ehlers A. New York: Plenum Press; 1991:81-96.
  • [52]Lansbergen MM, Van Dongen-Boomsma M, Buitelaar JK, Slaats-Willemse D: ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study. J Neural Transm 2011, 118:275-284.
  • [53]Logemann HN, Lansbergen MM, Van Os TW, Bocker KB, Kenemans JL: The effectiveness of EEG-feedback on attention, impulsivity and EEG: a sham feedback controlled study. Neurosci Lett 2010, 479:49-53.
  • [54]Cobb DE, Evans JR: The use of biofeedback techniques with school-aged children exhibiting behavioural and⁄or learning problems. J Abnorm Child Psych 1981, 9:251-81.
  • [55]Dunn FM, Howell RJ: Relaxation training and its relationship to hyperactivity in boys. J. Clinical Psychology 1982, 38:92-100.
  • [56]Denkowski KM, Denkowski GC, Omizo MM: The effects of EMG-assisted relaxation training on the academic performance, locus of control, and self–esteem of hyperactive boys. Biofeedback Self Regul 1983, 8:363-375.
  • [57]Potashkin BD, Beckles N: Relative efficacy of ritalin and biofeedback treatments in the management of hyperactivity. Biofeedback Self Regul 1990, 15:305-315.
  • [58]Arnold LE: Alternative treatments for adults with attention-deficit hyperactivity disorder (ADHD). Ann NY Acad Sci 2001, 931:310-341.
  • [59]Maurizio S, Liechti MD, Brandeis D, Jäncke L, Drechsler R: Differential EMG biofeedback for children with ADHD: a control method for neurofeedback training with a case illustration. Appl Psychophysiol Biofeedback 2013, 38:109-119.
  • [60]Bakhshayesh AR, Haensch S, Wyschkon A, Rezai MJ, Esser G: Neurofeedback in ADHD: a single-blind randomized controlled trial. Eur Child Adolesc Psychiatry 2011, 9:481-491.
  • [61]Rains JC, Penzien DB: Behavioral research and the double-blind placebo-controlled methodology: challenges in applying the biomedical standard to behavioral headache research. Headache 2005, 45:479-486.
  • [62]Surwit RS, Keefe FJ: The blind leading the blind: problems with the "double-blind“ design in clinical biofeedback research. Biofeedback Self Regul 1983, 8:1-2.
  • [63]Doehnert M, Brandeis D, Schneider G, Drechsler R, Steinhausen HC: A neurophysiological marker of impaired preparation in an 11-year follow-up study of attention-deficit/hyperactivity disorder (ADHD). J Child Psychol Psychiatry 2013, 54:260-270.
  • [64]Holtmann M: Commentary: Persistent time estimation deficits in ADHD? From developmental trajectories to individual targets for intervention–reflections on Doehnert et al. (2013). J Child Psychol Psychiatry 2013, 54:271-272.
  文献评价指标  
  下载次数:23次 浏览次数:6次